220 related articles for article (PubMed ID: 34747522)
21. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
22. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.
Robert SM; Buckingham SC; Campbell SL; Robel S; Holt KT; Ogunrinu-Babarinde T; Warren PP; White DM; Reid MA; Eschbacher JM; Berens ME; Lahti AC; Nabors LB; Sontheimer H
Sci Transl Med; 2015 May; 7(289):289ra86. PubMed ID: 26019222
[TBL] [Abstract][Full Text] [Related]
23. Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells.
Chintala S; Li W; Lamoreux ML; Ito S; Wakamatsu K; Sviderskaya EV; Bennett DC; Park YM; Gahl WA; Huizing M; Spritz RA; Ben S; Novak EK; Tan J; Swank RT
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10964-9. PubMed ID: 16037214
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of cell proliferation in neurogenic zones in mice lacking cystine transport by xCT.
Liu RR; Brown CE; Murphy TH
Biochem Biophys Res Commun; 2007 Dec; 364(3):528-33. PubMed ID: 17963724
[TBL] [Abstract][Full Text] [Related]
25. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
Uno K; Takarada T; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Pharmacol Sci; 2011; 115(3):309-19. PubMed ID: 21325781
[TBL] [Abstract][Full Text] [Related]
26. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
Savaskan NE; Hahnen E; Eyüpoglu IY
J Cell Physiol; 2009 Aug; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
[No Abstract] [Full Text] [Related]
27. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
28. Redox States of Protein Cysteines in Pathways of Protein Turnover and Cytoskeleton Dynamics Are Changed with Aging and Reversed by Slc7a11 Restoration in Mouse Lung Fibroblasts.
Zheng Y; Merchant ML; Burke TJ; Ritzenthaler JD; Li M; Gaweda AE; Benz FW; Roman J; Watson WH
Oxid Med Cell Longev; 2020; 2020():2468986. PubMed ID: 32587657
[TBL] [Abstract][Full Text] [Related]
29. Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter.
Bentea E; Villers A; Moore C; Funk AJ; O'Donovan SM; Verbruggen L; Lara O; Janssen P; De Pauw L; Declerck NB; DePasquale EAK; Churchill MJ; Sato H; Hermans E; Arckens L; Meshul CK; Ris L; McCullumsmith RE; Massie A
Mol Psychiatry; 2021 Sep; 26(9):4754-4769. PubMed ID: 32366950
[TBL] [Abstract][Full Text] [Related]
30. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
31. Impaired long-term potentiation and long-term memory deficits in xCT-deficient sut mice.
Li Y; Tan Z; Li Z; Sun Z; Duan S; Li W
Biosci Rep; 2012 Jun; 32(3):315-21. PubMed ID: 22394266
[TBL] [Abstract][Full Text] [Related]
32. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
33. Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat.
La Bella V; Valentino F; Piccoli T; Piccoli F
Neurochem Res; 2007 Jun; 32(6):1081-90. PubMed ID: 17401668
[TBL] [Abstract][Full Text] [Related]
34. Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model.
Demuyser T; Deneyer L; Bentea E; Albertini G; Femenia T; Walrave L; Sato H; Danbolt NC; De Bundel D; Michotte A; Lindskog M; Massie A; Smolders I
World J Biol Psychiatry; 2019 Jun; 20(5):381-392. PubMed ID: 28882088
[No Abstract] [Full Text] [Related]
35. Structural investigation of human cystine/glutamate antiporter system x
Hang TD; Hung HM; Beckers P; Desmet N; Lamrani M; Massie A; Hermans E; Vanommeslaeghe K
Front Mol Biosci; 2022; 9():1064199. PubMed ID: 36533083
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of spermatic cystine/glutamate antiporter xCT (SLC7A11) influences the ability of cryopreserved stallion sperm to bind to heterologous zonae pellucidae.
Ortiz-Rodriguez JM; Nerozzi C; Bucci D; Mislei B; Mari G; Tamanini C; Peña FJ; Spinaci M; Galeati G
Theriogenology; 2021 Jun; 167():24-31. PubMed ID: 33743505
[TBL] [Abstract][Full Text] [Related]
37. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
38. Transport of cystine across xC
Ghasemitarei M; Yusupov M; Razzokov J; Shokri B; Bogaerts A
Arch Biochem Biophys; 2019 Mar; 664():117-126. PubMed ID: 30738038
[TBL] [Abstract][Full Text] [Related]
39. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target.
Albrecht P; Lewerenz J; Dittmer S; Noack R; Maher P; Methner A
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):373-82. PubMed ID: 20053169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
